NIH-funded research NIH-funded research

Donepezil’s effect on aging muscles and resilience

Official title: Impacts of Donepezil on Skeletal Muscle Strength, Quality, and Resilience during Aging

Funded at University of Kansas Medical Center · NIH-11268518 · Data updated 2026-11-12

A patient-friendly look at how a drug used for memory problems might help aging muscles stay stronger and more resilient.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Kansas Medical Center
NIH-funded
Lab location1 site (Kansas City, United States)
Project startSeptember 1, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$198,999
NIH project number1P20GM162002-01
Project IDNIH-11268518 on NIH RePORTER

Who could benefit from this research

Could help

Older adults who are at risk for aging-related muscle weakness or frailty (or who are showing early signs) may benefit from future applications of this research.

Less likely to help

Patients without aging-related muscle weakness or those not likely to respond to cholinesterase inhibitors may see little to no benefit.

What this research studies

This project explores whether donepezil, a medicine already used for cognitive issues, can help older adults keep their muscle strength and function when facing stress or illness. Researchers will test donepezil in animal models and examine its effects on muscle mitochondria, energy production, and overall muscle health as we age. The goal is to find ways to prevent frailty and disability by boosting resilience in the muscles that support everyday activities.

Why it matters

Potential benefit: If successful, this work could lead to strategies that help older adults maintain muscle strength and recover better after health stressors.

How similar studies have gone: Earlier findings suggest donepezil may improve muscle mitochondrial function and strength in aging models, supporting the potential for benefit.

Where this research is happening

  • University of Kansas Medical Center
    Kansas City, United States
    Active

Researchers

  • Principal investigator: Mccoin, Colin — University of Kansas Medical Center
  • Study coordinator: Mccoin, Colin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.